Society Pass (SOPA) Competitors

Society Pass (NASDAQ:SOPA) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, community ranking, risk, earnings, profitability, analyst recommendations and valuation.

Which has preferable earnings & valuation, SOPA or BIAF?

bioAffinity Technologies has lower revenue, but higher earnings than Society Pass. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Society Pass, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Society Pass	$8.17M	0.46	-$18.13M	-$5.12	-0.20
bioAffinity Technologies	$2.53M	4.12	-$7.94M	-$0.82	-0.81

Do institutionals & insiders hold more shares of SOPA or BIAF?

3.1% of Society Pass shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 5.6% of Society Pass shares are owned by company insiders. Comparatively, 35.1% of bioAffinity Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in SOPA or BIAF?

Society Pass received 7 more outperform votes than bioAffinity Technologies when rated by MarketBeat users. However, 100.00% of users gave bioAffinity Technologies an outperform vote while only 72.73% of users gave Society Pass an outperform vote.

Company	Underperform	Outperform
Society Pass	Outperform Votes 8 72.73%	Underperform Votes 3 27.27%
bioAffinity Technologies	Outperform Votes 1 100.00%	Underperform Votes No Votes

Is SOPA or BIAF more profitable?

bioAffinity Technologies has a net margin of -91.22% compared to Society Pass' net margin of -171.10%. bioAffinity Technologies' return on equity of -205.09% beat Society Pass' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Society Pass	-171.10%	-431.98%	-79.26%
bioAffinity Technologies	-91.22%	-205.09%	-115.95%

Does the media prefer SOPA or BIAF?

In the previous week, bioAffinity Technologies had 1 more articles in the media than Society Pass. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Society Pass. Society Pass' average media sentiment score of 0.00 equaled bioAffinity Technologies'average media sentiment score.

Company	Overall Sentiment
Society Pass	Neutral
bioAffinity Technologies	Neutral

Which has more volatility and risk, SOPA or BIAF?

Society Pass has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.98, suggesting that its share price is 198% more volatile than the S&P 500.

Do analysts recommend SOPA or BIAF?

Society Pass currently has a consensus target price of $16.00, suggesting a potential upside of 1,460.98%. bioAffinity Technologies has a consensus target price of $6.00, suggesting a potential upside of 798.20%. Given Society Pass' higher possible upside, research analysts clearly believe Society Pass is more favorable than bioAffinity Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Society Pass	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
bioAffinity Technologies	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

bioAffinity Technologies beats Society Pass on 10 of the 16 factors compared between the two stocks.